Roivant Sciences Stock Current Asset
| ROIV Stock | USD 12.15 0.05 0.41% |
Roivant Sciences fundamentals help investors to digest information that contributes to Roivant Sciences' financial success or failures. It also enables traders to predict the movement of Roivant Stock. The fundamental analysis module provides a way to measure Roivant Sciences' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Roivant Sciences stock.
At this time, Roivant Sciences' Other Current Assets are fairly stable compared to the past year. Total Current Assets is likely to climb to about 7.1 B in 2024, whereas Non Current Assets Total are likely to drop slightly above 436.9 M in 2024. Roivant | Current Asset |
Roivant Sciences Company Current Asset Analysis
Roivant Sciences' Current Asset is all of the company's assets that can be used to pay off current liabilities within the current fiscal period or over the next 12 months. Current Asset includes cash or cash equivalents, accounts receivable, short-term investments, and the portion of prepaid liabilities which will be paid within the next 12 months. Because these assets are easily turned into cash, they are sometimes referred to as liquid assets.
Roivant Current Asset Historical Pattern
Today, most investors in Roivant Sciences Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Roivant Sciences' growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's current asset growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of Roivant Sciences current asset as a starting point in their analysis.
Roivant Sciences Current Asset |
| Timeline |
Current Asset is important to company's creditors and private equity firms as they will often be interested in how much that company has in current assets since these assets can be easily liquidated in case the company goes bankrupt. However, it is usually not enough to know if a company is in good shape just based on current asset alone; the amount of current liabilities should always be considered.
| Competition |
Roivant Total Assets
Total Assets |
|
In accordance with the recently published financial statements, Roivant Sciences has a Current Asset of 0.0. This is 100.0% lower than that of the Biotechnology sector and 100.0% lower than that of the Health Care industry. The current asset for all United States stocks is 100.0% higher than that of the company.
Roivant Current Asset Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Roivant Sciences' direct or indirect competition against its Current Asset to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Roivant Sciences could also be used in its relative valuation, which is a method of valuing Roivant Sciences by comparing valuation metrics of similar companies.Roivant Sciences is currently under evaluation in current asset category among its peers.
Roivant Sciences ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Roivant Sciences' sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Roivant Sciences' managers, analysts, and investors.Environmental | Governance | Social |
Roivant Fundamentals
| Return On Equity | 1.29 | ||||
| Return On Asset | -0.18 | ||||
| Profit Margin | 37.25 % | ||||
| Operating Margin | (74.46) % | ||||
| Current Valuation | 3.51 B | ||||
| Shares Outstanding | 727.95 M | ||||
| Shares Owned By Insiders | 28.92 % | ||||
| Shares Owned By Institutions | 79.48 % | ||||
| Number Of Shares Shorted | 47.81 M | ||||
| Price To Book | 1.72 X | ||||
| Price To Sales | 68.49 X | ||||
| Revenue | 124.8 M | ||||
| Gross Profit | (477.06 M) | ||||
| EBITDA | 4.31 B | ||||
| Net Income | 4.23 B | ||||
| Cash And Equivalents | 1.94 B | ||||
| Cash Per Share | 2.76 X | ||||
| Total Debt | 499.75 M | ||||
| Debt To Equity | 0.28 % | ||||
| Current Ratio | 6.20 X | ||||
| Book Value Per Share | 7.03 X | ||||
| Cash Flow From Operations | (765.27 M) | ||||
| Short Ratio | 9.58 X | ||||
| Earnings Per Share | 5.54 X | ||||
| Target Price | 16.25 | ||||
| Number Of Employees | 908 | ||||
| Beta | 1.24 | ||||
| Market Capitalization | 8.84 B | ||||
| Total Asset | 7.22 B | ||||
| Retained Earnings | 576.17 M | ||||
| Working Capital | 6.47 B | ||||
| Net Asset | 7.22 B |
About Roivant Sciences Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Roivant Sciences's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Roivant Sciences using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Roivant Sciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Roivant Stock Analysis
When running Roivant Sciences' price analysis, check to measure Roivant Sciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Roivant Sciences is operating at the current time. Most of Roivant Sciences' value examination focuses on studying past and present price action to predict the probability of Roivant Sciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Roivant Sciences' price. Additionally, you may evaluate how the addition of Roivant Sciences to your portfolios can decrease your overall portfolio volatility.